Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Ruiz-Garcia

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Molecular Pharmaceutics|July 21, 2012
Role of the equilibrative and concentrative nucleoside transporters in the intestinal absorption of the nucleoside drug, ribavirin, in wild-type and Ent1(-/-) miceAaron M Moss, Christopher J Endres, Ana Ruiz-Garcia, et al.
Cancer Chemotherapy and Pharmacology|June 14, 2013
A phase I, open-label, mass balance study of [(14)C] dacomitinib (PF-00299804) in healthy male volunteersCarlo L Bello, Evan Smith, Ana Ruiz-Garcia, et al.
Clinical and Translational Science|August 20, 2020
Characterization of the Relationship of Inotuzumab Ozogamicin Exposure With Efficacy and Safety End Points in Adults With Relapsed or Refractory Acute Lymphoblastic LeukemiaJoseph Chen, May Haughey, Erik Vandendries, et al.
The Journal of Investigative Dermatology. Symposium Proceedings|May 16, 2007
Pharmacokinetics of murine p75-Fc fusion protein and MP6-XT22 anti-murine TNF-alpha mAb in miceScott G Filler, Norma V Solis, Jane Guo, et al.
Cancer Chemotherapy and Pharmacology|January 16, 2015
Effect of axitinib on the QT interval in healthy volunteersAna Ruiz-Garcia, Brett E Houk, Yazdi K Pithavala, et al.
Clinical and Translational Science|June 19, 2026
Thorough QT/QTc Clinical Study to Evaluate the Effect of Remdesivir on Cardiac Repolarization in Healthy ParticipantsChi-Chi Peng, Ran Duan, Mazin Abdelghany, et al.
Clinical Pharmacology and Therapeutics|May 11, 2021
Lorlatinib Exposure-Response Analyses for Safety and Efficacy in a Phase I/II Trial to Support Benefit-Risk Assessment in Non-Small Cell Lung CancerJoseph Chen, Ana Ruiz-Garcia, Leonard P James, et al.
Journal of Clinical Pharmacology|September 26, 2023
Pharmacokinetics and Metabolism of Melflufen, an Alkylating Peptide-Drug Conjugate, in Patients with Relapsed Refractory Multiple MyelomaGunilla Huledal, Ana Ruiz-Garcia, Sonoko Kawakatsu, et al.
Cancer Chemotherapy and Pharmacology|October 23, 2014
Pharmacokinetics of single-agent axitinib across multiple solid tumor typesMichael A Tortorici, Ezra E W Cohen, Yazdi K Pithavala, et al.
Clinical and Translational Science|June 3, 2021
Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndromeRena Eudy-Byrne, Nicole Zane, Susan C Adeniyi-Jones, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Molecular Pharmaceutics|July 21, 2012
Role of the equilibrative and concentrative nucleoside transporters in the intestinal absorption of the nucleoside drug, ribavirin, in wild-type and Ent1(-/-) miceAaron M Moss, Christopher J Endres, Ana Ruiz-Garcia, et al.
Cancer Chemotherapy and Pharmacology|June 14, 2013
A phase I, open-label, mass balance study of [(14)C] dacomitinib (PF-00299804) in healthy male volunteersCarlo L Bello, Evan Smith, Ana Ruiz-Garcia, et al.
Clinical and Translational Science|August 20, 2020
Characterization of the Relationship of Inotuzumab Ozogamicin Exposure With Efficacy and Safety End Points in Adults With Relapsed or Refractory Acute Lymphoblastic LeukemiaJoseph Chen, May Haughey, Erik Vandendries, et al.
The Journal of Investigative Dermatology. Symposium Proceedings|May 16, 2007
Pharmacokinetics of murine p75-Fc fusion protein and MP6-XT22 anti-murine TNF-alpha mAb in miceScott G Filler, Norma V Solis, Jane Guo, et al.
Cancer Chemotherapy and Pharmacology|January 16, 2015
Effect of axitinib on the QT interval in healthy volunteersAna Ruiz-Garcia, Brett E Houk, Yazdi K Pithavala, et al.
Clinical and Translational Science|June 19, 2026
Thorough QT/QTc Clinical Study to Evaluate the Effect of Remdesivir on Cardiac Repolarization in Healthy ParticipantsChi-Chi Peng, Ran Duan, Mazin Abdelghany, et al.
Clinical Pharmacology and Therapeutics|May 11, 2021
Lorlatinib Exposure-Response Analyses for Safety and Efficacy in a Phase I/II Trial to Support Benefit-Risk Assessment in Non-Small Cell Lung CancerJoseph Chen, Ana Ruiz-Garcia, Leonard P James, et al.
Journal of Clinical Pharmacology|September 26, 2023
Pharmacokinetics and Metabolism of Melflufen, an Alkylating Peptide-Drug Conjugate, in Patients with Relapsed Refractory Multiple MyelomaGunilla Huledal, Ana Ruiz-Garcia, Sonoko Kawakatsu, et al.
Cancer Chemotherapy and Pharmacology|October 23, 2014
Pharmacokinetics of single-agent axitinib across multiple solid tumor typesMichael A Tortorici, Ezra E W Cohen, Yazdi K Pithavala, et al.
Clinical and Translational Science|June 3, 2021
Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndromeRena Eudy-Byrne, Nicole Zane, Susan C Adeniyi-Jones, et al.
Pageof 4